Want to see IN:METROPOLIS full AI Analyst Report?
METROPOLIS Stock Chart & Stats
₹1929.70
-₹8.50(-0.42%)
At close: 4:00 PM EST
₹1929.70
-₹8.50(-0.42%)
Day’s Range― - ―
52-Week Range₹413.00 - ₹599.90
Previous CloseN/A
Volume139.28K
Average Volume (3M)3.90K
Market Cap
₹118.83B
Enterprise Value₹114.81B
Total Cash (Recent Filing)₹1.18B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)61.7
Beta0.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.21%
Share Statistics
EPS (TTM)N/A
Shares Outstanding207,327,770
10 Day Avg. Volume4,604
30 Day Avg. Volume3,901
Financial Highlights & Ratios
PEG Ratio1.58
Price to Book (P/B)5.93
Price to Sales (P/S)5.45
P/FCF Ratio30.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLeverage declined materially over multiple years and equity has grown with assets, giving the company durable financial flexibility. A low debt base supports capital expenditure, inorganic opportunities and resilience in downturns, reducing refinancing and liquidity risk long term.
Strong Cash GenerationConsistent positive operating and free cash flow, with a notable step-up in FY2026, underpins self-funded growth and reinvestment capacity. Reliable cash generation supports lab network expansion, working capital needs and lowers dependence on external financing over the medium term.
Re-accelerating Revenue GrowthA rebound to mid-teens revenue growth shows strengthening demand and recovery in test volumes. Sustained top-line momentum supports scale, better absorption of fixed costs and the potential to restore earlier peak profitability if cost control remains disciplined over the next several quarters.
Bears Say
Profitability VolatilityOperating margins and reported earnings have swung across years, leaving earnings quality uneven. Persistent margin volatility undermines forecasting, could limit reinvestment choices, and raises execution risk that modest top-line gains may not consistently translate into durable profit improvement.
Cash Conversion VariabilityYear-to-year swings in cash conversion indicate working-capital or timing volatility. That variability can strain liquidity in specific periods, complicate capital allocation, and force short-term financing or deferment of investments despite overall positive free cash flow over longer horizons.
Debt Tick-up WatchAlthough leverage remains modest, the recent uptick in debt in FY2026 reverses prior deleveraging momentum. If the trend continues it could constrain flexibility, increase interest expense sensitivity and modestly elevate financial risk relative to the firm's historically conservative capital structure.
Metropolis Healthcare Ltd. News
METROPOLIS FAQ
What was Metropolis Healthcare Ltd.’s price range in the past 12 months?
Metropolis Healthcare Ltd. lowest stock price was ₹413.00 and its highest was ₹599.90 in the past 12 months.
What is Metropolis Healthcare Ltd.’s market cap?
Metropolis Healthcare Ltd.’s market cap is ₹118.83B.
When is Metropolis Healthcare Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Metropolis Healthcare Ltd.’s earnings last quarter?
Currently, no data Available
Is Metropolis Healthcare Ltd. overvalued?
According to Wall Street analysts Metropolis Healthcare Ltd.’s price is currently Overvalued.
Does Metropolis Healthcare Ltd. pay dividends?
Metropolis Healthcare Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.21%. See more information on Metropolis Healthcare Ltd. dividends here
What is Metropolis Healthcare Ltd.’s EPS estimate?
Metropolis Healthcare Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Metropolis Healthcare Ltd. have?
Metropolis Healthcare Ltd. has 207,327,770 shares outstanding.
What happened to Metropolis Healthcare Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Metropolis Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:METROPOLIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Metropolis Healthcare Ltd.
Metropolis Healthcare Limited functions as a prominent diagnostic service provider throughout India. The company delivers a comprehensive array of clinical laboratory testing, specialized diagnostic profiles, and associated support services. Its capabilities span diverse medical fields, encompassing oncology, neurology, gynecology, and nephrology. Furthermore, Metropolis offers a variety of health check-up packages specifically tailored for different demographic groups, including men, women, senior citizens, youth, and corporate clients. These tests are vital for disease prediction, early identification, diagnostic screening, confirmation, and continuous monitoring. Beyond its core diagnostic offerings, the company also extends its expertise to corporate wellness programs, hospital laboratory management solutions, and clinical research. As of March 31, 2022, Metropolis had established an extensive network comprising 171 clinical laboratories, 9,000 sample collection points, and 704 assisted referral centers. Founded in 1980, the company's corporate headquarters are situated in Mumbai, India.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Thyrocare Technologies Ltd
―
Vijaya Diagnostic Centre Ltd.
―
Vimta Labs Limited
―